---
category: news
title: "Hepion Pharmaceuticals to Present on CRV431 and AI-POW(TM) at NASH-TAG 2021"
excerpt: "EDISON, NJ / ACCESSWIRE / / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) (\"Hepion\"), a clinical stage biopharmaceutical company focused on Artificial Intelligence (\"AI\")-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (\"NASH\") and liver disease,"
publishedDateTime: 2021-03-12T02:22:00Z
originalUrl: "https://www.marketwatch.com/press-release/hepion-pharmaceuticals-to-present-on-crv431-and-ai-powtm-at-nash-tag-2021-2021-03-11-142645816"
webUrl: "https://www.marketwatch.com/press-release/hepion-pharmaceuticals-to-present-on-crv431-and-ai-powtm-at-nash-tag-2021-2021-03-11-142645816"
type: article
quality: 67
heat: 67
published: false

provider:
  name: MarketWatch
  domain: marketwatch.com
  images:
    - url: "https://smartableai.github.io/artificial-intelligence/assets/images/organizations/marketwatch.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png"
    width: 1200
    height: 630
    isCached: true

secured: "NIhr2MMyzJhuQUVFIwnsyqWDscXV8kIblyz3pFo4fRYqasfj1AujBxoYcx+Pg3FTeKWHVOSJm+vRlSO4iAW2YxNHAONGysuZn7cAXk20KbYzafVx03KDQgBzCb8nzqWvzgbDBOj1+1oUPO0MOydBjDfIq3x/IZAdwcm1f6taGm9yQoKSVDHVhZ9h9wnWm6oQ3AwmDZ434tNxF7mMvi+tMJ5TrYzrlVSxeH2oQW8QrtOM+muOEKinSSiDng2yNsUkmipNCf1oQipl9bLYwBdOLzKiZNIpMwuFZFXUaP7ay2RH5J5QvuFF29DoDp10bwOEfmzYU15S8iIvg73D0T8UKJaVC/L0OdKVvCMe4nizgFo=;LKAXh9TNUlLwaNVAE7xrZw=="
---

